Loading stock data…
MetaVia Inc. (MTVA)
N/A
MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases.
Historical Price
No chart data available for MTVA
Synthesizing Whystock Narrative...
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$4.03M↓ | -$2.05M↑ | -$3.48M↑ | -$4.30M↓ | -$3.89M |
| Net Income | -$3.82M↓ | -$1.93M↑ | -$3.38M↑ | -$4.00M↓ | -$3.67M |
Peer Comparison
JNJUNHPFE
Fundamentals
MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases. The company develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standa...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$13.84M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-144.66%
Volume
Today's trading volume
-
Recent News
Sector Update: Healthcare Stocks Gain Late Afternoon
Healthcare stocks rose late Tuesday afternoon, with the NYSE Healthcare Index and the State Street H
Sector Update: Healthcare Stocks Rise Tuesday Afternoon
Healthcare stocks rose Tuesday afternoon, with the NYSE Healthcare Index adding 1.1% and the State S
We're Keeping An Eye On MetaVia's (NASDAQ:MTVA) Cash Burn Rate
Just because a business does not make any money, does not mean that the stock will go down. For example, although...